CYTK · Cytokinetics Inc · Insider Trading
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-11-09 | PARSHALL B LYNNE |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction involves sale transactions from $53.72 to $54.69 per share. The weighted average price per share was $54.17. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price |
Common Stock
|
2,445 |
| 2026-11-09 | PARSHALL B LYNNE |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported transaction involves sale transactions from $54.78 to $55.71 per share. The weighted average price per share was $55.26. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price |
Common Stock
|
2,555 |
| 2026-11-03 | Malik Fady Ibraham |
Officer |
Convert↓
|
Non-Qualified Stock Option (Right to Buy)
|
3,500 |
| 2026-11-03 | Malik Fady Ibraham |
Officer |
Convert↑
|
Common Stock
|
3,500 |
| 2026-11-03 | Malik Fady Ibraham |
Officer |
Sell↓
|
Common Stock
|
3,500 |
| 2026-11-02 | Blum Robert I |
Director, President & CEO |
Convert↓
|
Non-Qualified Stock Option (Right to Buy)
|
7,500 |
| 2026-11-02 | Blum Robert I |
Director, President & CEO |
Convert↑
|
Common Stock
|
7,500 |
| 2026-11-02 | Blum Robert I |
Director, President & CEO |
Sell↓
|
Common Stock
|
7,500 |
| 2026-10-20 | Malik Fady Ibraham |
Officer |
Convert↑
|
Common Stock
|
3,500 |
| 2026-10-20 | Malik Fady Ibraham |
Officer |
Sell↓
|
Common Stock
|
3,500 |
| 2026-10-20 | Malik Fady Ibraham |
Officer |
Convert↓
|
Non-Qualified Stock Option (Right to Buy)
|
3,500 |
| 2026-10-16 | Wysenski Nancy |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Director equity in lieu of cash retainer program. |
Common Stock
|
97 |
| 2026-10-16 | Harrington Robert Arthur |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Director equity in lieu of cash retainer program. |
Common Stock
|
195 |
| 2026-10-16 | Daly James M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Director equity in lieu of cash retainer program. |
Common Stock
|
195 |
| 2026-10-16 | HENDERSON JOHN T |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Director equity in lieu of cash retainer program. |
Common Stock
|
352 |
| 2026-10-16 | WIERENGA WENDELL |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Director equity in lieu of cash retainer program. |
Common Stock
|
97 |
| 2026-10-16 | Kaye Edward M. MD |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Director equity in lieu of cash retainer program. |
Common Stock
|
195 |
| 2026-10-12 | Blum Robert I |
Director, President & CEO |
Convert↓
|
Non-Qualified Stock Option (Right to Buy)
|
7,500 |
| 2026-10-12 | Blum Robert I |
Director, President & CEO |
Sell↓
|
Common Stock
|
7,500 |
| 2026-10-12 | Blum Robert I |
Director, President & CEO |
Convert↑
|
Common Stock
|
7,500 |
| 2026-10-06 | Malik Fady Ibraham |
Officer |
Convert↓
|
Non-Qualified Stock Option (Right to Buy)
|
3,500 |
| 2026-10-06 | Malik Fady Ibraham |
Officer |
Convert↑
|
Common Stock
|
3,500 |
| 2026-10-06 | Malik Fady Ibraham |
Officer |
Sell↓
|
Common Stock
|
3,500 |
| 2026-09-28 | Blum Robert I |
Director, President & CEO |
Convert↑
|
Common Stock
|
7,500 |
| 2026-09-28 | Blum Robert I |
Director, President & CEO |
Sell↓
|
Common Stock
|
7,500 |
| 2026-09-28 | Blum Robert I |
Director, President & CEO |
Convert↓
|
Non-Qualified Stock Option (Right to Buy)
|
7,500 |
| 2026-09-22 | Malik Fady Ibraham |
Officer |
Convert↑
|
Common Stock
|
3,500 |
| 2026-09-22 | Malik Fady Ibraham |
Officer |
Sell↓
|
Common Stock
|
3,500 |
| 2026-09-22 | Malik Fady Ibraham |
Officer |
Convert↓
|
Non-Qualified Stock Option (Right to Buy)
|
3,500 |
| 2026-09-15 | Landry Robert E |
Director |
Sell↓
|
Common Stock
|
1,000 |
| 2026-09-15 | Blum Robert I |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Indirect)
Sale of shares of common stock by The Bridget Blum 2026 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the shares sold or the proceeds thereof. |
Common Stock
(I)
|
97,926 |
| 2026-09-14 | Blum Robert I |
Director, President & CEO |
Gift↑
Filing footnotes — Common Stock (Indirect)
Acquisition of shares by The Bridget Blum 2026 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the shares held by the aforementioned trust. |
Common Stock
(I)
|
97,926 |
| 2026-09-14 | Blum Robert I |
Director, President & CEO |
Convert↑
Filing footnotes — Common Stock (Direct)
Acquisition of shares of common stock upon exercise of stock options. Transaction is pursuant to a trading plan adopted by the reporting person intended to satisfy the conditions of Rule 10b5-1(c). |
Common Stock
|
7,500 |
| 2026-09-14 | Blum Robert I |
Director, President & CEO |
Gift↓
Filing footnotes — Common Stock (Direct)
Transfer of shares of common stock to The Bridget Blum 2026 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the shares held by the aforementioned trust upon completion of the gift transfer. |
Common Stock
|
97,926 |
| 2026-09-14 | Blum Robert I |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
Sale of shares of common stock acquired upon exercise of stock options. Transaction is pursuant to a trading plan adopted by the reporting person intended to satisfy the conditions of Rule 10b5-1(c). |
Common Stock
|
7,500 |
| 2026-09-14 | Blum Robert I |
Director, President & CEO |
Gift↓
Filing footnotes — Common Stock (Direct)
Charitable gift. |
Common Stock
|
1,350 |
| 2026-09-14 | Blum Robert I |
Director, President & CEO |
Convert↓
Filing footnotes — Non-Qualified Stock Option (Right to Buy) (Direct)
Exercise of stock options. Transaction is pursuant to a trading plan adopted by the reporting person intended to satisfy the conditions of Rule 10b5-1(c). |
Non-Qualified Stock Option (Right to Buy)
|
7,500 |
| 2026-09-11 | Landry Robert E |
Director |
Sell↓
|
Common Stock
|
1,000 |
| 2026-09-08 | Malik Fady Ibraham |
Officer |
Convert↓
|
Non-Qualified Stock Option (Right to Buy)
|
3,500 |
| 2026-09-08 | Malik Fady Ibraham |
Officer |
Convert↑
|
Common Stock
|
3,500 |
| 2026-09-08 | Malik Fady Ibraham |
Officer |
Sell↓
|
Common Stock
|
3,500 |
| 2026-09-01 | PARSHALL B LYNNE |
Director |
Sell↓
|
Common Stock
|
5,000 |
| 2026-08-31 | Callos Andrew |
EVP, Chief Commercial Officer |
Convert↑
|
Common Stock
|
10,000 |
| 2026-08-31 | Blum Robert I |
Director, President & CEO |
Convert↑
|
Common Stock
|
7,500 |
| 2026-08-31 | Callos Andrew |
EVP, Chief Commercial Officer |
Sell↓
|
Common Stock
|
10,000 |
| 2026-08-31 | Blum Robert I |
Director, President & CEO |
Sell↓
|
Common Stock
|
7,500 |
| 2026-08-31 | Blum Robert I |
Director, President & CEO |
Convert↓
|
Non-Qualified Stock Option (Right to Buy)
|
7,500 |
| 2026-08-31 | Callos Andrew |
EVP, Chief Commercial Officer |
Convert↓
Filing footnotes — Non-Qualified Stock Option (Right to Buy) (Direct)
Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer. |
Non-Qualified Stock Option (Right to Buy)
|
10,000 |
| 2026-08-18 | Malik Fady Ibraham |
Officer |
Convert↑
|
Common Stock
|
3,500 |
| 2026-08-18 | Malik Fady Ibraham |
Officer |
Convert↓
|
Non-Qualified Stock Option (Right to Buy)
|
3,500 |